In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.
Protocol No: Onco_Covid-19
Version no:1.0
Objectives: Firstly the patients recently diagnosed with cancer will be selected for
enrollment who are on active treatment during lockdown based on the date of their
registration in the hospital. This is followed by a telephonic interview with patients or
their attendant to carry out a prospective, cross-sectional, observational study in order to
address the issues and challenges faced by them during Lockdown.
Collection of data will be done through telephonic communication. Participation in this study
will be entirely voluntary. Telephonic verbal consent will be taken from the patients or
their attendants before collection of their response on the study questionnaire and then will
be asked questions accordingly based on the questionnaire which is available in English and
Hindi both. Data and general information regarding participants will only be collected in
questionnaire. No personal data of the participants will be taken which will also be conveyed
to the participant or attendant during telephonic verbal consent.
Inclusion Criteria:
- Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020
- Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery,
radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020
Exclusion Criteria:
-
Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre
New Delhi, India
Investigator: Rajesh Saxena
Contact: 9818474003
rajesh.saxena@maxhealthcare.com
Rajesh Saxena
9818474003
rajesh.saxena@maxhealthcare.com
Geeta Kadayaprath, Principal Investigator
Max Hospital, Patparganj